The present paper explored the possibility of discriminating between different malignant degrees of Chondrosarcoma (CS), a diffused bone tumor, and Enchondroma (EC), its benign version, through an approach based on the coupling between Confocal Raman Microscopy (CRM) and Machine Learning (ML) techniques. Recently, Raman Spectroscopy has proven to be a powerful tool for a complete grading of CS by distinguishing between grade 1, 2 and 3, and to distinguish CS from EC. In this paper, we tested some models, belonging either to ML or to the sub-type called Deep Learning (DL), showing excellent classification performances, especially the DL algorithms, with classification accuracy approaching to 100%, making the models promising for future implementations of Raman spectroscopy when applied to oncology diagnosis. In turn, we highlighted how some proper ML models result in worse classification performances but better resolution of specific chemical target compounds, possible candidate to become malignant markers, with relevant implication for a correct diagnosis.
No takes yet. Share an insight, caveat, or question.
Lazzini et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: